FSTL3 is a biomarker of poor prognosis and associated with immunotherapy resistance in ovarian cancer
FSTL3是卵巢癌预后不良的生物标志物,且与免疫治疗耐药性相关。
期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03425-4
Chauvin, Maeva; Tromelin, Estelle; Roche-Prellezo, Julien; Lancia, Hyshem H; Meinsohn, Marie-Charlotte; Coletti, Caroline; Nguyen, Ngoc Minh Phuong; Lafont, Virginie; Michaud, Henri-Alexandre; Mishra, Ranjan; Bonnefoy, Nathalie; Gros, Laurent; Pépin, David